RIBOSIME, METHOD OF INACTIVATION OF RNA-TARGET, METHOD OF RIBOSIME PREPARING Russian patent published in 2000 - IPC

Abstract RU 2144080 C1

FIELD: molecular biology, biochemistry. SUBSTANCE: invention relates to synthetic single-stranded RNA molecules showing highly specific endonuclease activity. Ribosime has hybridizing and catalytic regions. Hybridizing region has one or more branches of a single-stranded RNA. The preferable ribosime has a catalytic region including the sequence AAGC*GAGXAGUC in "hairpin" N1* N2 structure where * means bases pairing between complementary nucleotides, X means any ribonucleotide and N1 and N2 mean ribonucleotides with complementary sequences, at least, in part of their length. Ribosime splits RNA-target after triplet xUy where x is any ribonucleotide, U means uracil and y is adenine, cytosine or uracil. The nucleotide sequence encoding the required ribosime is obtained followed by its ligation with a suitable transfer vector containing DNA or RNA or their combination. The ligated sequence is transcribed using RNA-polymerase. RNA-target into the cells is subjected by ribosime effect that is able to carry out the specific cleavage of indicated RNA-target in the site taken so manner that the indicated RNA-target is hybridized into the cell with ribosime to induce inactivation of RNA-target. Invention ensures to obtain ribosimes that are able to hybridize effectively with the broad raw of target RNA-sequences but without modifying the cleavage RNA-targent. EFFECT: improved method of ribosime preparing. 11 cl, 38 dwg, 9 ex

Similar patents RU2144080C1

Title Year Author Number
RECOMBINANT DNA AS AGENT FOR INHIBITION OF RNA FUNCTION IN LIVING ORGANISM 1990
  • Khartmut Bojg
  • Maks Birnshtil'
  • Mes'Ju Kotten
  • Ehrnst Vagner
  • Kharal'D Kandol'F
RU2136751C1
METHODS AND COMPONENTS FOR INDUCTION OF TUMOR- -SPECIFIC CYTOTOXICITY 1998
  • Khokhberg Abrakham
  • Ajesh Sukhail
RU2214280C2
SUBSTRATES OF NUCLEIC ACIDS WITH ENZYMATIC ACTIVITY 2012
  • Todd Elison Velijan
  • Mokejni Elajza
  • Lajnardi Evelin Mejria
  • Lonergen Dajna
RU2650806C2
TREATMENT OF FIBROBLAST GROWTH FACTOR 21 (FGF21) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO FGF21 2011
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2610661C2
TREATMENT OF ALPHA-L-IDURONIDASE (IDUA) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IDUA 2011
  • Kollard Dzhozef
  • Khorkova Sherman Olga
  • Kojto Karlos
  • Gang Shen
RU2597972C2
TREATMENT OF DISEASES CONNECTED WITH SITE-1 MEMBRANE-IMPACTED PEPTIDASE OF TRANSCRIPTION FACTORS (MBTPS1), BY INHIBITING NATURAL ANTISENSE TRANSCRIPT TO MBTPS1 2010
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2639550C2
CRISPR-CAS SYSTEM COMPONENTS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION 2013
  • Chzhan Fen
  • Bikard Devid Olive
  • Tsun Le
  • Koks Devid Bendzhamin Turits
  • Khsyu Patrik
  • Tszyan Venyan
  • Lin Shaujlyan
  • Marraffini Luchano
  • Platt Rendol Dzheffri
  • Zhan Fej
  • Sandzhana Nevill Espi
RU2701662C2
SYSTEMS FOR EXPRESSION OF NEWCASTLE DISEASE VIRUS RECOMBINANT RNA AND VACCINES 1999
  • Garsia-Sastre Adol'Fo
  • Palez Piter
RU2270864C2
TREATMENT OF DISEASES ASSOCIATED WITH SUBSTRATE OF INSULIN RECEPTOR 2 (IRS2) BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IRS2 2010
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2616283C2
GENETIC MAKE-UPS FOR ANTI-HIV THERAPY 2010
  • Glazkova Dina Viktorovna
  • Vetchinova Anna Sergeevna
  • Bogoslovskaja Elena Vladimirovna
  • Markelov Mikhail Leonidovich
  • Shipulin German Aleksandrovich
  • Kuevda Dmitrij Aleksandrovich
  • Pokrovskij Valentin Ivanovich
  • Pokrovskij Vadim Valentinovich
RU2426788C1

RU 2 144 080 C1

Authors

Dzhejms Filip Khejsloff

Vejn Lajl Gerlach

Filip Ehntoni Dzhennings

Fiona Khelen Kameron

Dates

2000-01-10Published

1988-12-14Filed